
Gameto Launches First U.S. Clinical Site for Patient Enrollment in Fertilo Study
Gameto Launches First U.S. Clinical Site for Patient Enrollment in Fertilo Study Gameto, a clinical-stage biotechnology company at the forefront of developing cutting-edge iPSC (induced pluripotent stem cell)-based therapies to revolutionize fertility care, today announced an exciting milestone in its…